Analysis of Efficacy and Survival Prognosis for Astragalus Polysaccharide Injection as Adjuvant Therapy in Non - Small Cell Lung Cancer: A Propensity Score Matching - Based Study
Jinying Li, Yifei Zhang, Xuemei Wang, Zhongyu Ding, Na Zhu, Yuan Chen, Yongli Li, Chuangxin Lu · 2025
Read Analysis of Efficacy and Survival Prognosis for Astragalus Polysaccharide Injection as Adjuvant Therapy in Non - Small Cell Lung Cancer: A Propensity Score Matching - Based Study by Jinying Li, Yifei Zhang, Xuemei Wang, Zhongyu Ding, Na Zhu, Yuan Chen, Yongli Li, Chuangxin Lu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12766121.txt.
Description
Li and co-authors study in 2025 whether an herbal extract shot helps patients with the most common type of lung cancer when added to standard care. The extract is thought to tune the immune system, but survival proof was weak. They used matched records to compare like patients fairly.
Records from 2018 to 2024 gave 54 matched pairs, half with the extract added. Response and control rates were far higher in the extract group. Median time without growth and median survival were also longer in that group in the head's figures. Immune function, quality of life, and side effects were also tracked in the study.
Catalog record
| CREATOR | Jinying Li, Yifei Zhang, Xuemei Wang, Zhongyu Ding, Na Zhu, Yuan Chen, Yongli Li, Chuangxin Lu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |